Publications

Filter by Category

Filter by Program

Filter by Publish Date

December 1, 2024

Advancing rare disease measurement through the Rare Disease Clinical Outcome Assessment Consortium

Naomi Knoble, and Lindsey T. Murray on behalf of the Rare Disease Clinical Outcome Assessment Consortium. View all authors and aff

September 30, 2024

Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...

October 8, 2024

Estelle Haenel, Celeste A. Elash, Katie Garner, Megan Turner, Scottie KernAbstract Electronic Clinical Outcome Assessment (eCOA) C

September 27, 2024

Purpose Determining if group-level differences in health outcomes are meaningful has recently been neglected...

August 1, 2024

It is estimated that more than 350 million people worldwide live with a rare disease.

July 29, 2024

C-Path and experienced private sector partners collaborated with global health organizations to create didactic video materials...

June 12, 2024

Digital measures may provide objective, sensitive, real-world measures of disease progression in Parkinson’s disease (PD).

May 28, 2024

Artificial Intelligence (AI) and Digital Health Technologies (DHTs) are radically transforming drug development. The FDA and EMA..

April 22, 2024

Recent breakthroughs in natural language processing (NLP), particularly in large language models (LLMs), offer substantial...

February 1, 2024

Parkinson's disease and dementia with Lewy bodies are currently defined by their clinical features, with α-synuclein pathology...